A research team identifies a metabolic footprint associated with the perception of satiety

February 22, 2021

The regulation of satiety is an important factor that determines a higher or lower intake of energy and, therefore, has a considerable impact on the development and/or progression of obesity. The team made up of the researchers Lucia Camacho Barcia, Jesús García-Gavilán, Christopher Papandreou, and Mònica Bulló that leads the research group in Nutrition and Metabolic Diseases of the Department of Biochemistry and Biotechnology (Universitat Rovira i Virgili - Tarragona-Spain) have worked  with researchers from Denmark and the United Kingdom to identify a group of metabolites in the blood that is related to a greater perception of satiety after eating.

The study was carried out in 140 volunteers suffering from overweight and obesity, and has showed that higher concentrations of glycine and linoleic acid are associated with a greater sensation of satiety, while saccharose and some sphingomyelins  (C32:2, C38:1) are negatively associated (that is to say, with a lower perception of satiety). Although metabolomics has been widely used in nutritional research, this is the first time it has been used to study the perception of satiety. These results not only contribute to designing possible strategies for measuring satiety more objectively than the habitual methods but also to a better understanding of the metabolic routes involved in regulating satiety which may, in the future lead to a useful tool for designing more effective strategies for controlling appetite and body weight.

This research is part of a wider study (SATIN - SATiety INnovation) that was carried out to assess the extent to which the regulation of satiety can contribute to controlling body weight in the medium term. The results have been published elsewhere. The study published recently focuses on the metabolic aspects of regulating hunger and satiety. The analyses were carried out with the data collected from satiety tests. To this end, 151 volunteers from the SATIN study went to the recruiting centres after fasting. Once there they were given a controlled breakfast and the satiety data were collected in the subsequent two hours. The volunteers were also given lunch while they were still on the premises and they were given an evening meal to take away so the researchers had controlled data about the food eaten throughout the day. The satiety tests were carried out on several occasions during the study.

By identifying the substances that make it possible to predict satiety, more personalised nutrition programmes can be implemented and products can be designed to control hunger and satiety by increasing or decreasing the concentration of these metabolites in blood.
-end-
Reference: Camacho-Barcia L, García-Gavilán J, Papandreou C, Hansen TT, Harrold JA, Finlayson G, Blundell JE, Sjödin A, Halford JCG, Bulló M. Circulating "Metabolites Associated with Postprandial Satiety in Overweight/Obese Participants: The SATIN Study". Nutrients. 2021 Feb 8;13(2):549. doi: 10.3390/nu13020549. PMID: 33567505.

Universitat Rovira i Virgili

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.